Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001764013-24-000148
Filing Date
2024-08-06
Accepted
2024-08-06 16:19:40
Documents
56
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q imvt-20240630.htm   iXBRL 10-Q 1082792
2 EX-31.1 exhibit311-2024630q1.htm EX-31.1 9756
3 EX-31.2 exhibit312-2024630q1.htm EX-31.2 9753
4 EX-32.1 exhibit321-2024630q1.htm EX-32.1 4458
5 EX-32.2 exhibit322-2024630q1.htm EX-32.2 4479
  Complete submission text file 0001764013-24-000148.txt   4415131

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imvt-20240630.xsd EX-101.SCH 26478
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imvt-20240630_cal.xml EX-101.CAL 37549
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imvt-20240630_def.xml EX-101.DEF 151382
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imvt-20240630_lab.xml EX-101.LAB 446264
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imvt-20240630_pre.xml EX-101.PRE 305452
59 EXTRACTED XBRL INSTANCE DOCUMENT imvt-20240630_htm.xml XML 317291
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

EIN.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38906 | Film No.: 241179586
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)